EUVIMEDEUVIMED entdecken
Crossref

Low-dose hydrogen sulfide ameliorates cisplatin-induced hepatotoxicity in rats

Kudret Ensarioğlu Baktır, Mehmet Günata, Onural Özhan, Recep Bentli, Nigar Vardı, Yusuf Türköz, Azibe Yıldız, Ahmet Acet, Hakan Parlakpınar

Recent Trends in Pharmacology · 2025

DOI: 10.62425/rtpharma.1549787 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Recent Trends in Pharmacology, 2025. Verfasst von Kudret Ensarioğlu Baktır und 8 weiteren Autor:innen. Die Arbeit nennt 71 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Cisplatin (CIS) is non-specific to the cell cycle, has a cytotoxic effect, and is used in many cancers. The side effects of CIS, such as hepatotoxicity, seriously limit its clinical use. This experimental study aims to prevent hepatotoxicity, one of the clinical side effects that cisplatin may cause. At the same time, Hydrogen sulfide (H2S) will be applied prophylactically and therapeutically and its effect levels will be compared. This study aims to contribute to the literature by preventing dose restriction due to the hepatotoxicity side effect of cisplatin, which plays an important role in cancer treatment, by prophylactic application of H2S. Our study investigated the protective and therapeutic efficacy of sodium hydrosulfide (NaHS, a donor of H2S), which activates the antioxidant system on CIS-induced hepatotoxicity.

Method

Control (Vehicle), CIS (7.5 mg/kg CIS), H2S+CIS (10 µmol/kg NaHS+7.5 mg/kg CIS), CIS+H2S (7.5 mg/kg CIS+10 µmol/kg NaHS) groups were formed by using 35 rats in the study. At the end of the study, blood and liver tissue was taken, and histopathological and biochemical analyzes were performed.

Results

It was determined that sinusoidal dilatation and congestion increased significantly in the CIS group and decreased in the H2S+CIS and CIS+H2S groups. Likewise, glycogen loss occurred in the CIS group, and a significant improvement was observed in the H2S+CIS group. In addition, significant deterioration was detected in malondialdehyde, catalase, glutathione, aspartate aminotransferase, alanine aminotransferase, and lactate dehydrogenase values in the CIS group compared to the control group. In contrast, significant improvements were observed in both the H2S+CIS and CIS+H2S groups compared to the CIS group.

Conclusion

Both protective and therapeutic beneficial effects of H2S in CIS-induced hepatotoxicity were demonstrated by histopathological and biochemical analyses.

Zitieren

APA

Baktır, K. E., Günata, M., Özhan, O., Bentli, R., Vardı, N., Türköz, Y., Yıldız, A., Acet, A., & Parlakpınar, H. (2025). Low-dose hydrogen sulfide ameliorates cisplatin-induced hepatotoxicity in rats. Recent Trends in Pharmacology. https://doi.org/10.62425/rtpharma.1549787

Vancouver

Baktır KE, Günata M, Özhan O, Bentli R, Vardı N, Türköz Y, et al. Low-dose hydrogen sulfide ameliorates cisplatin-induced hepatotoxicity in rats. Recent Trends in Pharmacology. 2025. doi:10.62425/rtpharma.1549787

BibTeX
@article{Baktr2025,
  author = {Baktır, Kudret Ensarioğlu and Günata, Mehmet and Özhan, Onural and Bentli, Recep and Vardı, Nigar and Türköz, Yusuf and Yıldız, Azibe and Acet, Ahmet and Parlakpınar, Hakan},
  title = {Low-dose hydrogen sulfide ameliorates cisplatin-induced hepatotoxicity in rats},
  journal = {Recent Trends in Pharmacology},
  year = {2025},
  doi = {10.62425/rtpharma.1549787}
}
Kostenlos starten →